News on Eli Lilly and Company

Biotech investment offers cash rich value plus investment: The StreetSignal Report

2010-03-01T19:15:12Z

<div id="subtitle">Focus on U.S. healthcare costs could be catalyst for biotech investment</div><div><p>U.S. Hospital study a very important (and unrecognized) catalyst for BioMS Success </p><p>Heading into 2009 we selected (through my microcap.com newsletter and on Stockhouse) only one biotech to follow for the year. That was YM Biosciences (TSX: T.YM, Stock Forum) in the 30s and 40s. W...

A bottle of pills to kick the bottle

2010-02-24T22:16:54Z

<div><p>LONDON (Reuters) - Does this sound like anyone you know? Darryl is 35, has a steady job, a stable home and good marriage, enjoys a few beers in front of the TV most nights -- doesn't have what most people would call a drink problem.</p><p>In the United States alone there are probably around 36 million Darryls, according to the Attorney General Dustin McDaniel says the state has reached an $18.5 million settlement with Eli Lilly &amp; Co. over improper marketing of an anti-psychotic medication.</p><p>McDaniel said Tuesday the settlement covers state Medicare ...

Eli Lily Pays Mississippi $18.5 Million to Settle Zyprexa Claim

2010-02-22T11:36:06Z

<div id="subtitle">Money arrives at critical time, state says</div><div><p>The State of Mississippi has recovered some much needed cash, as drug giant Eli Lilly has agreed to an $18.5 million fraud settlement over the drug Zyprexa.</p><p>The ...

Earns Elil Lilly

2010-01-28T08:31:28Z

FILE - In this Jan. 11, 2008 file photo, a bottle of Eli Lilly & Co.'s Prozac is pictured at a company facility in Plainfield, Ind. Drugmaker Eli Lilly and Co. said Thursday, Jan, 28, 2010, it turned a fourth-quarter profit on higher-than-expected revenue, but...

U.S. warnings target Bayer, Amylin, Cephalon, Lilly

2010-02-22T21:31:53Z

<div><p>WASHINGTON (Reuters) - The U.S. Food and Drug Administration's marketing office has warned Bayer AG, Amylin Pharmaceuticals Inc and Eli Lilly &amp; Co. pharmaceutical fortune, dies at 94</div><div><p>Ruth Lilly, a prolific philanthropist who was the last surviving great-grandchild of pharmaceutical magnate Eli Lilly, has died at age 94.</p><p>A family spokesman said Lilly died Wednesday in Eli Lilly to pay Incyte $90M upfront in licensing deal for potential anti-inflammatory drug</div><div><p>Eli Lilly &amp; Co. and Incyte Corp. said Monday they will develop a potential treatment for inflammatory and autoimmune diseases in a deal valued at $90 million upfront ...

Eli Lilly Guidance

2009-12-10T09:17:32Z

FILE - In this April 10, 2003 file photo, bottles filled with the drug Zyprexa sits on the packaging line at the Eli Lilly & Co. Dry Products Packaging Facility in Indianapolis. Eli Lilly said Thursday, Dec. 10, 2009, it still expects its earnings per share to grow in the double-digit range through 2011 and added it plan...

Swiss fine drug firms $5.7M for price-fixing

2010-02-23T22:37:28Z

<div id="subtitle">Swiss fine Pfizer, Eli Lilly, Bayer $5.7M for price-fixing of erectile dysfunction drugs</div><div><p>The Swiss branches of Pfizer Inc., Eli Lilly &amp; Co. and Bayer AG were fined a total of 5.7 million francs ($5.7 million) by competition ...

Eli Lilly head of research, development to retire

2010-02-24T05:54:34Z

<div id="subtitle">Lilly says science and technology head will retire, to be replaced by AstraZeneca counterpart</div><div><p>Eli Lilly &amp; Co. said Friday its science and technology head will retire. The drugmaker hired the chief researcher at AstraZeneca PLC to replace him.</p>...

APNewsBreak: SC AG reaches $45M deal with Lilly

2010-02-24T15:11:38Z

<div><p>South Carolina's attorney general says the state has reached a $45 million settlement with drug maker Eli Lilly &amp; Co. over the company's marketing of an anti-psychotic drug.</p><p>Henry McMaster's office said Friday that the agreement is the second-largest settlement deal in state history....

GE launches $250 million health care tech fund

2010-02-24T16:09:25Z

<div><p>GE Healthcare said Wednesday it plans to expand a cancer drug research partnership with Eli Lilly &amp; Co., making a two-year-old partnership official in the process.</p><p>General Electric Co. Zyprexa sit on the packaging line at the Eli Lilly & Co. Lilly on Wednesday, Oct. 21, 2009 said its worldwide revenue rose 7 percent with its top-selling Zyprexa, bringing in $1.2 billion, or 3 percent more than it did the same quarter last year. (AP Photo/Darron Cummings, file)

Eli Lilly settlement over marketing of Zyprexa</div><div><p>Connecticut officials say Eli Lilly &amp; Co. has agreed to a $25 million settlement with the state over claims the drugmaker marketed its anti-psychotic drug Zyprexa for unapproved uses and harmed pat...

Adolor buys rights to Eli Lilly drug

2010-02-25T04:31:36Z

<div id="subtitle">Adolor buys rights to Eli Lilly drug, plans studies on opioid bowel dysfunction</div><div><p>Biotechnology company Adolor Corp. said Monday it bought exclusive worldwide rights to Eli Lilly &amp; Co.'s OpRA III drug candidate, which has a range of potential uses.</p&a...

GlaxoSmithKline changes doctor training policy

2010-02-25T04:42:38Z

<div><p>British drugmaker GlaxoSmithKline PLC said Monday it is making major changes in its funding of educational programs for doctors, reducing the number it sponsors and switching its focus to independent ones with balanced information.</p><p>The change follows similar moves by some major competitors — possibly concerned about proposed federal rules that could be tough...

Eli Lilly Reorganization

2009-09-14T12:17:16Z

FILE - In this Jan 25, 2006 file photo, The Eli Lilly and Company headquarters in pictured in Indianapolis. Drugmaker Eli Lilly & Co. said Monday, Sept. 14, 2009, that it will eliminate 5,500 jobs, or nearly 14 percent of its staff, and reorganize into five business units in order to slash costs and speed up development of potential new drugs. (AP Photo/Darron Cumming...

Dyax receives $1.5 million payment

2010-02-25T15:31:34Z

<div id="subtitle">Dyax receives $1.5 million payment as partner Eli Lilly's ImClone moves drug into development</div><div><p>Biotechnology company Dyax Corp. said Wednesday it received a $1.5 million payment as Eli Lilly &amp; Co. moved ...

Lilly will not seek FDA approval for arzoxifene

2010-02-25T18:42:36Z

<div id="subtitle">Eli Lilly will not ask for approval of osteoporosis drug based on study data, safety concerns</div><div><p>Eli Lilly &amp; Co. said Tuesday it will not seek Food and Drug Administration approval for its developing postmenopausal osteoporosis drug because ...